iSOFT wins $17.4m in contract extensions in Northern Ireland for Clinicom patient management system.

Screening process completed for phase II clinical trial of interferon to treat influenza.

WA Health licenses iSOFT Patient Manager hospital information system.

CSL subsidiary, Biotherapies, wins multimillion dollar order for Novel A (H1N1) influenza vaccine from the US Government

Point-of-care testing is an emerging field within community medicine and will be discussed at this week's South Pacific Congress in Auckland.

Following a rancorous and polarising public debate last year, the creation of embryonic stem cell lines through somatic cell nuclear transfer will become legal in Australia on June 12.

The National Blood Authority has refreshed its IT infrastructure to cope with the increasing complexity of supply.

Denmark's Bavarian Nordic is actively seeking to be part of the consolidation process now underway in the international vaccine industry, and would not turn down a takeover offer if the price were right, company chairman Asgar Aamund said on Tuesday.

Western Australia's agriculture minister, Kim Chance, is taking what many are now seeing as an overly cautious stance on biotechnology. Graeme O'Neill reports.

Melbourne-based Biota Holdings (ASX:BTA) has entered into a licensing and collaboration agreement with US company MedImmune (Nasdaq:MEDI) to develop and commercialise Biota's small molecule compounds for the prevention and treatment of respiratory syncytial virus (RSV) infection.